HRSA curtails pandemic-era 340B flexibilities for hospitals’ off-campus outpatient facilities
In an expected move that stands to affect the savings reaped by health systems from the 340B Drug Pricing Program, the Health Resources and Services Administration (HRSA) is tightening participation requirements for off-campus outpatient facilities. In a published alert, HRSA announced plans to end pandemic-related flexibilities that have made it easier for off-campus outpatient facilities…
Amid positive signs financially, hospitals continue to grapple with high costs in labor and other areas
The latest financial metrics for the hospital sector reflect a period of increasing stability but also sustained challenges. August financial data from more than 1,300 hospitals, as reported by Syntellis Performance Solutions, showed improvements in key metrics. The month-over-month increase in median operating margin was 3.5 percentage points, helping the year-to-date margin rise to 1.4%…
Healthcare labor union activity gains steam: The consequences for hospitals and health systems
Note: The lead section of this article was updated Oct. 16 with news of a tentative agreement between Kaiser Permanente and the unions. When around 75,000 staff at Kaiser Permanente went on strike for three days starting Oct. 4, they represented more than just the largest-ever labor stoppage in the healthcare industry. They also exemplified…
Insights on population health management challenges through the eyes of C-suite leaders
Population health management is at a crossroads, and one key to ensuring its viability is to bolster stakeholder trust in the potential of value-based payment (VBP) models. That was a key takeaway from healthcare executives who took part in a September panel discussion at the 23rd annual Population Health Colloquium, hosted by the Jefferson College…
Healthcare News of Note: Most nursing facilities are short staffed under CMS’s proposed long-term care rule, says KFF
Over the past few weeks, I have found these industry news stories that should be of interest to healthcare finance professionals. 1. CMS’s proposed rule puts nursing facilities in a tough spot Fewer than 1 in 5 nursing facilities would meet hours-per-resident-per-day (HPRD) provisions outlined in CMS’s new proposed rule for long-term care facilities, which…
Solving the nursing crisis: 3 lessons learned from the COVID-19 experience
Accounts of the nursing shortage may vary in emphasis, but the contours of the crisis are plain: The United States does not have enough nurses to deliver the high quality of patient care that all healthcare organizations are mandated to provide. This challenge is driving healthcare facilities to rethink how they staff themselves in the…
The intersection of quality and finance, with Rick Gundling and Stephanie Mercado
HFMA's Rick Gundling and Stephanie Mercado from the National Association for Healthcare Quality discuss how all entities within a healthcare organization can work for better quality.
Published data quantify how cost increases will continue to affect the healthcare industry next year
The cost to treat patients will accelerate next year, with ramifications across the healthcare industry, according to newly published projections. PwC’s Health Research Institute reported that the cost of providing care will increase by 7% in 2024, up from a 6% increase this year and 5.5% in 2022. A 7% increase would tie 2021 for…
Summary: 10 vital responses to healthcare disruption
Note: This article is a summary of a report on HFMA’s Spring Thought Leadership Retreat. The full report is available to download. Disruption is reverberating throughout the healthcare industry, and it’s incumbent on legacy organizations to develop strategic responses for the benefit of their consumers, their communities and themselves. With that overarching challenge becoming ever…
Prices of drugs for diabetes, heart failure and more will be up for negotiation in Medicare next year
The U.S. Department of Health and Human Services (HHS) on Tuesday announced the first 10 Medicare Part D drugs that will be subject to price negotiations, the headlining healthcare-related provision of the Inflation Reduction Act. Signed in August 2022, the law gave Medicare authority to negotiate with drug manufacturers over the prices of selected drugs.…